Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Peter Church who wrote (392)	3/9/1997 11:55:00 AM
From: scaram(o)uche	of 6136

I've still got mine. And, I don't see the scene as anything "holding up the FDA". If this approval comes by the end of this month or immediate vicinity, it won't have set a record for approval time, but it will be a darn fast review from anything other than a crixivan perspective. I don't know the elaspsed time that was taken for saquinavir approval as "first of class", but I'd bet it was significantly longer than the time that has thus far expired for Viracept. Further, wouldn't an approval in March or April mean that this would be one of the two or three fastest reviews in regulatory history, FDA or other major regulatory body?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next